MGI 114 acylfulvene: MOGN finalized an agreement to sponsor clinical trials of the anti-cancer agent.

MGI Pharma Inc. (MOGN), Minnetonka, Minn. Product: MGI 114 acylfulvene derived from a mushroom Indication: Solid tumors Status: MOGN finalized an agreement for the National Cancer Institute to sponso...